I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 56% ± 24% | |
| macrophage | 5 studies | 27% ± 14% | |
| connective tissue cell | 3 studies | 59% ± 25% | |
| myofibroblast cell | 3 studies | 37% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 7 studies | 56% ± 24% | |
| macrophage | 5 studies | 27% ± 14% | |
| connective tissue cell | 3 studies | 59% ± 25% | |
| myofibroblast cell | 3 studies | 37% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 3 studies | 25% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 72% | 9484.83 | 693 / 966 | 85% | 28.47 | 448 / 527 |
| stomach | 72% | 112.30 | 257 / 359 | 83% | 23.90 | 236 / 286 |
| lung | 68% | 100.04 | 392 / 578 | 75% | 18.57 | 864 / 1155 |
| bladder | 57% | 100.52 | 12 / 21 | 52% | 15.96 | 262 / 504 |
| breast | 43% | 71.56 | 199 / 459 | 58% | 13.71 | 652 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 185.92 | 29 / 29 |
| spleen | 99% | 449.97 | 239 / 241 | 0% | 0 | 0 / 0 |
| esophagus | 31% | 30.02 | 443 / 1445 | 55% | 8.18 | 100 / 183 |
| skin | 35% | 25.25 | 634 / 1809 | 49% | 12.90 | 230 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 20.40 | 36 / 45 |
| adrenal gland | 65% | 60.03 | 168 / 258 | 11% | 1.02 | 25 / 230 |
| prostate | 49% | 36.65 | 120 / 245 | 21% | 1.81 | 103 / 502 |
| adipose | 60% | 59.53 | 728 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 60% | 57.82 | 555 / 929 | 0% | 0 | 0 / 0 |
| uterus | 10% | 3.11 | 17 / 170 | 49% | 9.02 | 225 / 459 |
| thymus | 35% | 51.90 | 227 / 653 | 22% | 3.44 | 134 / 605 |
| pancreas | 14% | 5.57 | 46 / 328 | 43% | 7.34 | 76 / 178 |
| kidney | 20% | 20.78 | 18 / 89 | 36% | 5.72 | 320 / 901 |
| ovary | 9% | 5.99 | 17 / 180 | 43% | 6.90 | 184 / 430 |
| blood vessel | 38% | 62.29 | 512 / 1335 | 0% | 0 | 0 / 0 |
| liver | 8% | 3.01 | 18 / 226 | 13% | 2.06 | 54 / 406 |
| brain | 2% | 0.90 | 50 / 2642 | 18% | 2.91 | 126 / 705 |
| eye | 0% | 0 | 0 / 0 | 13% | 1.83 | 10 / 80 |
| heart | 6% | 2.31 | 49 / 861 | 0% | 0 | 0 / 0 |
| muscle | 2% | 2.07 | 15 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006955 | Biological process | immune response |
| GO_0007162 | Biological process | negative regulation of cell adhesion |
| GO_0006508 | Biological process | proteolysis |
| GO_0005576 | Cellular component | extracellular region |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | ADAMDEC1 |
| Protein name | ADAM like decysin 1 ADAM DEC1 (EC 3.4.24.-) (A disintegrin and metalloproteinase domain-like protein decysin-1) (ADAM-like protein decysin-1) |
| Synonyms | |
| Description | FUNCTION: May play an important role in the control of the immune response and during pregnancy. . |
| Accessions | O15204 E5RK05 ENST00000522298.1 [O15204-2] ENST00000256412.8 [O15204-1] ENST00000520193.1 |
